天水圍新都醫務中心為36人打超出建議使用日期復必泰 衛生署調查事件
衛生署表示,正調查和跟進天水圍嘉湖山莊新北江商場地下G3舖的新都綜合醫務中心(天水圍)為36名市民接種超出建議使用日期的復必泰疫苗。
衛生署於1月6日接獲上述醫務中心通報,於今年1月2及4日分別為12及24名市民接種解凍第31及第33天(即逾建議使用日期後的數小時及兩天)的復必泰疫苗。根據疫苗製造商的建議,復必泰疫苗需於解凍後儲存於攝氏2至8度,並於31天內使用。衛生署在接獲通報後到該醫務中心巡查,發現該醫務中心按照指引儲存疫苗於合適的溫度和環境。
衛生署得悉事件後,已即時向復星醫藥(02196.HK)查詢有關疫苗的安全、效能及質素資料。根據復星回覆,沒有資料顯示有因使用超過相關保存期疫苗而出現的不良反應。署方亦得悉有關疫苗解凍後兩個月的穩定性數據,並有待藥廠進一步確定。
署方已要求有關醫務中心跟進36位受影響市民的健康狀況,當中兩位巿民報稱腸胃不適,一人於急症室求診後正康復中,另一名市民現正留院觀察,情況穩定。其餘市民未有報稱不適。
衛生署亦已徵詢本地專家意見,初步評估認為是次疫苗接種有效,但為謹慎起見,建議受影響市民在完成整個疫苗療程後進行抗體水平測試,以確定有效性。署方會安排轉介專家跟進受影響人士。
署方亦已向涉事醫務中心發出警告,並敦促他們避免類似情況再次發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.